Dr. Rashmi Kanagal Shamanna is a tenured hematopathologist, molecular genetic pathologist and the director of the Clinical Microarray Facility in the CLIA-certified Molecular Diagnostic Laboratory. Her primary research interest is the application of novel molecular techniques to understand the pathogenesis of hematological malignancies and guide therapy, with over 125 highly cited peer-reviewed publications and multiple grants in her field. Dr. Kanagal-Shamanna is an elected member of multiple national organizations focused on appropriate utilization of genomic assays for patient care. She is an editorial board member for Cancer Genetics and an associate editor for Cancer Medicine journals.